Cargando…
Limited recovery from post-acute sequelae of SARS-CoV-2 at 8 months in a prospective cohort
In a longitudinal cohort, a significant proportion of patients had persistent symptoms 8 months after initial #COVID19 infection. There was no significant improvement in symptoms or health-related quality of life between 4- and 8-month assessments. https://bit.ly/2Wtb7IX
Autores principales: | Darley, David Ross, Dore, Gregory John, Byrne, Anthony Luke, Plit, Marshall Lawrence, Brew, Bruce James, Kelleher, Anthony, Matthews, Gail Veronica |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
European Respiratory Society
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8504133/ https://www.ncbi.nlm.nih.gov/pubmed/34725634 http://dx.doi.org/10.1183/23120541.00384-2021 |
Ejemplares similares
-
Laryngeal aspergilloma: a complication of inhaled fluticasone therapy for asthma
por: Darley, David, et al.
Publicado: (2014) -
The kynurenine pathway relates to post‐acute COVID‐19 objective cognitive impairment and PASC
por: Cysique, Lucette A., et al.
Publicado: (2023) -
(706) Prevalence and Risk Factors for Rejection Following COVID-19 in a Single Centre Australian Lung Transplant Cohort
por: Karas, P., et al.
Publicado: (2023) -
(704) Risk Factors for Persistent FEV(1)Decline Following COVID-19 Infection in Lung Transplant Recipients; a Single Australian Transplant Centre Experience
por: Thomson, C., et al.
Publicado: (2023) -
(705) Risk Factors for Death and Hospitalisation in COVID-19 Infection in Lung Transplant Recipients; a Single Australian Centre Experience
por: Thomson, C., et al.
Publicado: (2023)